Log in or Sign up for Free to view tailored content for your specialty!
Vascular Access News
Humacyte receives fast track designation for HumaGraft vascular access in hemodialysis program
The U.S. Food and Drug Administration has designated Humacyte Inc.'s HumaGraft development program for vascular access in hemodialysis patients as a Fast Track Development Program. HumaGraft is being developed to provide a vascular access alternative for hemodialysis patients to reduce or avoid certain serious complications associated with current forms of vascular access.
Fistula First offers new tools to improve outcomes
This year, the Fistula First Breakthrough Initiative has been updated and re-focused on the goal of increasing the use of AVFs
Log in or Sign up for Free to view tailored content for your specialty!
Cost of anticlotting medication in dialysis catheters may be offset by reduced complications
Using an expensive agent to prevent blood clots in kidney failure patients’ dialysis catheters may turn out to be less costly overall due to its ability to reduce medical complications, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
FDA approves new hemodialysis indication for Gore's Viabahn Endoprosthesis
The U.S Food and Drug Administration has granted indication for the Viabahn Endoprosthesis, made by W. L. Gore & Associates, to treat stenosis or thrombotic occlusion at the venous anastomosis of synthetic arteriovenous access grafts. This new indication allows for the use of the product in hemodialysis patients.
Early data show potential for investigational bioengineered blood vessel as dialysis grafts
An investigational, manufactured blood vessel used in vascular grafts for dialysis patients show encouraging early results among study patients in Poland, according to preliminary data reported Nov. 20 by a researcher at Duke Medicine.
Lowering catheter rates among hemodialysis patients
According to the 2013 annual data report from the United States Renal Data System, the use of catheters is the largest risk factor for infections among hemodialysis patients, and infection rates have increased 43% since 1993. The report also notes that this strong association between the use of catheters and the rate of infections among dialysis patients is well known within the dialysis community.
The CMO Initiative: Improving vascular access outcomes in dialysis patients
The critical role that the choice and utilization of the vascular access type has on clinical outcomes, especially infection rates, hospitalizations, and mortality, is well established
Cannulation techniques and vascular access issues facing dialysis staff
Stuart Mott, LPN, is the author of the article in NN&I's March 2013 issue, "Considerations at initiations of cannulation." He is a vascular access nurse from Millesburg, Mo.
Hospital research shows success improving catheter disinfection, lowering cost of patient care
Use of a simple disinfection cap on catheters can improve disinfection of IV catheters and lower the cost of care, according to research presented at the annual conference of the Association for Vascular Access Oct. 16-19 in San Antonio.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read